Very well constructed post @TerribleTadpole thanks for your thoughts and insights. Agree with all of your points.
Once the paper is published I'm sure there will be a huge amount of interest.
Not only with the share price in general but also with the product itself. IMO sales will increase across Europe. Extra media attention will drive this as well as peace of mind from parents looking to purchase the the mente autism device after such an extensive study has been concluded. The more the company proves itself the more sales it will generate.
The potential revenue streams for NTI are ginormous!!
Below is some information from @bonkers89 post some time ago, from the "NTI run down + clinical trial" thread
Post #:20781659
LOL and he was just talking about the Italian distribution agreement :
- Italian distribution- The existing contract for Min 8700 units has a 68% margin. This margin is incredible and not to mention the more they make which is inevitable the more margin that will be realised. What I have not seen mentioned here once is the fact that if the distributor wants to maintain its exclusive status which by all accounts they do they will have to sell min 20,000 units by July 2019.
- Let’s go though some calculations based on the information that I can confirm: (Option one they sell the min amount, note these figures are in AUD)
Wholesale cost to make= $951.00
$2451 RRP x 8700= $21,323,700 Revenue
$21,323,700 x 0.68 Margin= $14,500,000 Gross margin
- (Option Two they meet the 20,000-unit target to maintain exclusive status)
Wholesale cost to make= $951.00 (could be even less at this stage)
$2451 RRP x 20,000= $49,020,000 Revenue
$49,323,700 x 0.68 Margin= $33,333,600 Gross margin
As you can see these figures are very impressive even in the lowest of cases. Even more mind boggling is that this is only based on one area of the platform and one distributor/country with scope for many more target areas and countries which will follow suite very near term. It is key to keep in mind that the current MC is 34 million which is ridiculously low even for the base case option one which is going to be smashed soon."
END OF PARTIAL POST FROM @bonkers89
Yep go figure and now the market cap is even lower LMAO! What a steal the share price is at present! Bonkers thought the study was going to be concluded much, much sooner then he anticipated. "Smashed soon" now you can say soon old pal!
Come on guys push print, publish the findings and hopefully spread the good news...
Cheers
Red bar
- Forums
- ASX - By Stock
- NTI
- NTI - The run up to major announcement
NTI - The run up to major announcement, page-30
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NTI (ASX) to my watchlist
(20min delay)
|
|||||
Last
6.9¢ |
Change
0.002(2.99%) |
Mkt cap ! $64.55M |
Open | High | Low | Value | Volume |
6.7¢ | 7.2¢ | 6.7¢ | $45.29K | 648.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 684701 | 6.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.9¢ | 100000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 589299 | 0.070 |
1 | 36231 | 0.069 |
5 | 240000 | 0.068 |
2 | 255000 | 0.067 |
3 | 262000 | 0.066 |
Price($) | Vol. | No. |
---|---|---|
0.072 | 100000 | 1 |
0.074 | 40000 | 1 |
0.075 | 738582 | 2 |
0.076 | 90000 | 1 |
0.077 | 190000 | 3 |
Last trade - 15.37pm 22/11/2024 (20 minute delay) ? |
Featured News
NTI (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online